Overview: Entamoeba Antigen TestIntroduction: The Entamoeba Antigen Test detects Entamoeba antigens, indicating parasitic infection causing diarrhea or abdominal pain. Aligned with 2023 IDSA guidelines, it uses an immunoassay for high sensitivity, aiding in infectious disease screening. This test is critical for guiding diagnosis, treatment, and improving outcomes in parasitology for patients with suspected amoebiasis.
Other Names: Entamoeba histolytica Antigen Assay, Amoebiasis Test.
FDA Status: Laboratory-developed test (LDT), meeting parasitology standards for diagnostic accuracy.
Historical Milestone: Entamoeba antigen testing began in the 1990s with parasitic research. Immunoassays emerged in the 2000s, improving accuracy for amoebiasis diagnosis.
Purpose: Diagnoses Entamoeba infection, guides antiparasitic therapy, and monitors antigen presence in patients with diarrhea or abdominal pain.
Test Parameters: 1. Entamoeba Antigen
Pretest Condition: No fasting required. Collect stool at any time. Report symptoms like diarrhea or abdominal pain, and list travel to endemic areas or water exposure.
Specimen: 5-10 g stool (sterile container). Transport in a biohazard bag within 2 hours.
Sample Stability at Room Temperature: 2 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not frozen
Medical History: Document diarrhea, abdominal pain, or travel to Entamoeba-endemic areas. Include current medications, especially antiparasitics.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for antiparasitic therapy.
Procedural Considerations: Uses an immunoassay to detect Entamoeba antigens. Results are available in 1-2 days, enabling rapid clinical decisions.
Factors Affecting Result Accuracy: Improper storage or contamination can affect results. Early infection may cause false negatives.
Clinical Significance: Positive antigen results confirm Entamoeba infection, prompting antiparasitic therapy. Negative results may require microscopy or PCR.
Specialist Consultation: Consult an infectious disease specialist or gastroenterologist for result interpretation.
Additional Supporting Tests: Stool microscopy, Entamoeba PCR, or imaging to confirm amoebiasis.
Test Limitations: False negatives may occur with low antigen levels. Results require clinical correlation.
References: IDSA Parasitic Guidelines, 2023; Clinical Infectious Diseases, Fotedar R, 2022.
